Tag: immuno-oncology
CIRSE launch immuno-oncology trial alongside Immunophotonics
Immunophotonics has announced a collaboration with The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) around a phase 2/3 clinical trial.
The trial is designed...
Speakers shine light on current evidence for the ‘IOs’ and the...
Two of the sessions from day one of the 2023 European Conference on Interventional Oncology (ECIO; 16–19 April, Stockholm, Sweden) drew delegates’ focus to...
IO beyond interventional oncology: Progress in immuno-oncology
Recent advances in immuno-oncology are transforming the practice of medical oncology. Currently, antibodies directed against negative regulators of T-cell function, the so-called checkpoint inhibitors,...
Combination of immuno-oncology and liver-directed therapy: Where do we stand?
Ushering in “the era of IO”, Brad Wood calls for interventional oncologists to learn the language of immuno-oncology—“the other IO”—in order to improve care...
Interventional Oncology 2.0: Soul-searching to define our identity
Julius Chapiro and Lynn Savic claim there is “no need for scepticism” about the recent emergence and growth of immuno-oncology from an interventional oncologists’...
Surefire Medical appoints Mary T Szela CEO and president
Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and...
BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme
BTG and the Society of Interventional Oncology (SIO) have expanded their commitment to the Immuno-oncology /interventional oncology research grant programme, by announcing a second...
SIO announces first grants in interventional oncology /immuno-oncology research programme
The Society of Interventional Oncology (SIO and BTG have announced their 2017 Interventional interventional oncology /immuno-oncology research grant recipients.
The interventional oncology /immuno-oncology research programme...
Interventional oncology should identify “unmet immunotherapy needs”
Daniel Sze, speaking at the ninth annual Symposium on Clinical Interventional Oncology (CIO; 4–5 February 2017, Hollywood, USA), noted that immunotherapy is a “huge...
BTG and SIO to explore role of minimally invasive therapies in...
BTG has announced a collaboration with the Society of Interventional Oncology (SIO; a global organisation working to nurture and support interventional oncology worldwide) to...
